After Olivia Munn was diagnosed with breast cancer in 2023, she urged her mom and sister to take a risk assessment test.

However, despite this progress, NAMs are not consistently mentioned in the risk assessment frameworks for ingredients, with little flexibility for alternative approaches to be applied.